Rechallenge in advanced GIST progressing to imatinib, sunitinib and regorafenib: An Italian survey.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.11038
Abstract: 11038Background: We retrospectively collected data from metastatic Italian GIST patients treated with imatinib or sunitinib reintroduction after progression to conventional three or four lines of t... read more here.
Keywords: sunitinib regorafenib; imatinib sunitinib; advanced gist; gist progressing ... See more keywords